SKLB1028: Clinical Trials

1 trial of SKLB1028, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Unknown 1

Follow SKLB1028: new trials by email Literature Review of SKLB1028 trials Research Report on SKLB1028

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of SKLB1028 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory (R/R) AML With FLT3-Mutated
SKLB1028, Salvage Chemotherapy - Acute Myeloid Leukemia (AML)
Phase 3UnknownCSPC ZhongQi Pharmaceutical Technology Co., Ltd.3152021-03-242021-11-02

Conditions studied

Leukemia, Myeloid, Acute (1)

Sponsors

CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1)

Countries

China (1)